BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
BIOR
Delisted
BIOR was delisted on the 10th of December, 2024.
30 hedge funds and large institutions have $13.2M invested in Biora Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding
Funds holding: 30 → 30 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
Holders
30
Holding in Top 10
2
Calls
$4.6M
Puts
$392K
Top Buyers
| 1 | +$2.38M | |
| 2 | +$1.86M | |
| 3 | +$141K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$59.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24K |
Top Sellers
| 1 | -$73.5K | |
| 2 | -$45.4K | |
| 3 | -$39K | |
| 4 |
VF
Virtu Financial
New York
|
-$29K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$6.54K |